Merged Drug Company Attracts $15 Million Inviragen Will Test Vaccines in Madison
The Milwaukee Journal Sentinel › October 06, 2009
Linked as:
Summary
By PAUL GORES
A vaccine developer with a division in Madison is merging with a similar firm in Singapore, and together, they have raised $15 million in venture capital, the companies said Monday.See the full content of this document
Extract
Merged Drug Company Attracts $15 Million Inviragen Will Test Vaccines in Madison
The merger of Fort Collins, Colo.-based Inviragen LLC, which tests vaccines in Madison, and SingVax, of...
See the full content of this document
Sponsored links
